Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1987 1
1988 1
1990 3
1991 4
1994 1
1995 3
1996 3
1997 5
1998 2
1999 8
2000 4
2001 7
2002 8
2003 8
2004 20
2005 21
2006 15
2007 23
2008 22
2009 26
2010 26
2011 22
2012 37
2013 38
2014 51
2015 39
2016 39
2017 48
2018 39
2019 38
2020 45
2021 58
2022 61
2023 40
2024 52
2025 50

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

749 results

Results by year

Filters applied: . Clear all
Page 1
International Pediatric Otolaryngology Group: Consensus guidelines on the diagnosis and management of non-tuberculous mycobacterial cervicofacial lymphadenitis.
Roy CF, Balakrishnan K, Boudewyns A, Cheng A, Chun RH, Daniel SJ, Fayoux P, Hart C, Hemansson A, Hewitt R, Hsu WC, Kuo M, Liu C, Maddalozzo J, Messner AH, Pransky S, Rahbar R, Rickert S, Roy S, Russell J, Rutter MJ, Sie KCY, Sidell D, Smith R, Soma M, Spratley J, Watters K, White DR, Wolter N, Zalzal G, Yeung JC. Roy CF, et al. Among authors: hsu wc. Int J Pediatr Otorhinolaryngol. 2023 Mar;166:111469. doi: 10.1016/j.ijporl.2023.111469. Epub 2023 Feb 2. Int J Pediatr Otorhinolaryngol. 2023. PMID: 36764081 Review.
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study.
Rugo HS, Lerebours F, Ciruelos E, Drullinsky P, Ruiz-Borrego M, Neven P, Park YH, Prat A, Bachelot T, Juric D, Turner N, Sophos N, Zarate JP, Arce C, Shen YM, Turner S, Kanakamedala H, Hsu WC, Chia S. Rugo HS, et al. Among authors: hsu wc. Lancet Oncol. 2021 Apr;22(4):489-498. doi: 10.1016/S1470-2045(21)00034-6. Lancet Oncol. 2021. PMID: 33794206 Clinical Trial.
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study.
Rugo HS, Lerebours F, Ciruelos E, Drullinsky P, Ruiz-Borrego M, Neven P, Park YH, Prat A, Bachelot T, Juric D, Turner N, Sophos N, Zarate JP, Arce C, Shen YM, Turner S, Kanakamedala H, Hsu WC, Chia S. Rugo HS, et al. Among authors: hsu wc. Lancet Oncol. 2024 Dec;25(12):e629-e638. doi: 10.1016/S1470-2045(24)00673-9. Lancet Oncol. 2024. PMID: 39637900 Clinical Trial.
Revision adenoidectomy in children: a meta-analysis.
Lee CH, Hsu WC, Ko JY, Yeh TH, Lin MT, Kang KT. Lee CH, et al. Among authors: hsu wc. Rhinology. 2019 Dec 1;57(6):411-419. doi: 10.4193/Rhin19.101. Rhinology. 2019. PMID: 31403138 Review.
Antiviral natural products and herbal medicines.
Lin LT, Hsu WC, Lin CC. Lin LT, et al. Among authors: hsu wc. J Tradit Complement Med. 2014 Jan;4(1):24-35. doi: 10.4103/2225-4110.124335. J Tradit Complement Med. 2014. PMID: 24872930 Free PMC article. Review.
749 results